Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-11-16 Rodino-Klapac Louise Chief Scientific Officer Grant or award +40,000 61,898
2021-09-08 Estepan Ian Michael Chief Financial Officer Shares withheld for taxes −1,623 $78.29 $127K 26,753
2021-06-26 INGRAM DOUGLAS S President & CEO Shares withheld for taxes −17,812 $80.40 $1.4M 340,056
2021-06-01 Brown Ryan Edward SVP, General Counsel Shares withheld for taxes −64 $76.01 $5K 19,368
2021-03-10 BEHRENS M KATHLEEN Director Exercise or conversion +5,000 $42.30 $212K 135,517
2021-03-10 BEHRENS M KATHLEEN Director Sale −5,000 $85.76 $429K 130,517
2021-03-10 BEHRENS M KATHLEEN Director Exercise or conversion · Stock Option (right to buy) −5,000 0
2021-03-08 Wigzell Hans Lennart Rudolf Director Exercise or conversion +10,000 $34.92 $349K 26,518
2021-03-08 Wigzell Hans Lennart Rudolf Director Sale −10,000 $83.51 $835K 16,518
2021-03-08 Wigzell Hans Lennart Rudolf Director Exercise or conversion · Stock Option (right to buy) −10,000 0
2021-03-05 Estepan Ian Michael Chief Financial Officer Shares withheld for taxes −347 $84.65 $29K 28,376
2021-03-04 Brown Ryan Edward SVP, General Counsel Shares withheld for taxes −190 $80.76 $15K 19,432
2021-03-03 O'Neill Gilmore Neil EVP, R&D & CMO Grant or award +15,000 28,546
2021-03-03 Brown Ryan Edward SVP, General Counsel Grant or award +15,000 19,622
2021-03-03 Rodino-Klapac Louise Chief Scientific Officer Grant or award +15,000 21,780
2021-03-03 Estepan Ian Michael Chief Financial Officer Grant or award +15,000 28,723
2021-03-03 Wigzell Hans Lennart Rudolf Director Grant or award +2,726 16,518
2021-03-03 Wigzell Hans Lennart Rudolf Director Grant or award · Stock Option (right to buy) +5,518 5,518
2021-03-03 Rodino-Klapac Louise Chief Scientific Officer Grant or award +15,000 22,169
2021-03-03 Rodino-Klapac Louise Chief Scientific Officer Grant or award · Stock Option (right to buy) +60,000 60,000

Page 20 of 22 · 424 trades